Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The SOVEREIGN™ Spinal System is a fusion system intended for stabilization and to promote bone fusion during the normal healing process following surgical correction of disorders of the spine. The product should be implanted only by a physician thoroughly knowledgeable in the implant's material and surgical aspects and instructed as to its mechanical and material applications and limitations. This system may be implanted via a variety of open or minimally invasive approaches. These approaches include anterior and oblique.
The SOVEREIGN™ Spinal System is an intervertebral body fusion device with internal screw fixation. The screws protrude through the interbody portion of the device and stabilize the vertebral body while preventing expulsion of the implant. The implant is lens-shaped with 3 holes for placement of titanium screws using an anterior or oblique approach. The SOVEREIGN™ Spinal System contains both a fixed and a variable angle screw option. The fixed angle screw option provides an interference fit with the PEEK interbody implant. The variable angle screw option provides a slight clearance between the PEEK interbody implant and the screw which allows for a small amount of variable screw angulation. This system is intended to be radiolucent and the interior space of the product is to be used with autogenous bone graft. The accompanying cover plate is designed to resist screw backout and must be used when the variable angle screws are implanted.
The SOVEREIGN™ Spinal System interbody device is manufactured from PEEK (polyetheretherketone) and contains tantalum radiopaque markers. The screws used with this device are manufactured from titanium alloy.
The SOVEREIGN™ Spinal System is indicated for use with autogenous bone graft in patients with degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. Additionally, the SOVEREIGN™ Spinal System is indicated for use in patients diagnosed with deformity conditions as an adjunct to fusion. These patients should be skeletally mature and have had 6 months of non-operative treatment. The SOVEREIGN™ Spinal System is intended to be used with autograft and/or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft. These implants may be implanted via a variety of open or minimally invasive approaches. These approaches include anterior and oblique.
The SOVEREIGN™ interbody system may be used as a stand-alone device or in conjunction with supplemental fixation. When used as a stand-alone device, the SOVEREIGN™ interbody device is intended to be used with 3 titanium alloy fixed or variable angle screws. The accompanying cover plate MUST be used anytime the device is used with any number of variable
angle screws. If the physician chooses to use less than 3 or none of the provided screws, additional supplemental fixation in the lumbar spine must be used to augment stability. Implants with lordosis angles greater than 18° are intended to be used with supplemental fixation (e.g. facet screws or posterior fixation).
This device is not intended for cervical spine use. Contraindications include:
Nota bene: although not absolute contraindications, conditions to be considered as potential factors for not using this device include:
Adverse effects may occur when the device is used either with or without associated instrumentation. The risk of adverse effects as a result of movement and non-stabilization may increase in cases where associated complementary support is not employed. Potential adverse events include:
A successful result is not always achieved in every surgical case. This fact is especially true in spinal surgery where other patient conditions may compromise the results. Supplemental fixation systems which may be used with this device include: the CD HORIZON™ Spinal System, the TSRH™ Spinal System, the DYNALOK™ Classic Spinal System, the Z-PLATE II™ Anterior Fixation System, the PYRAMID™ Anterior Plate Fixation System, and/or their successors. When additional support instrumentation is used, refer to the package insert for requirements and limitations related to those devices.
Patients with previous spinal surgery at the levels to be treated may have different clinical outcomes compared to those without a previous spinal surgery.
Use of this product without autogenous bone graft may not be successful. No spinal implant can withstand body loads without the support of bone. In this event, bending, loosening, disassembly, and/or breakage of the device will eventually occur.
Preoperative and operating procedures, including knowledge of surgical techniques, proper selection and placement of the implant, and good reduction are important considerations in the success of surgery.
Never reuse an internal fixation device under any circumstances. Even when a removed device appears undamaged, it may have small defects or internal stress patterns that may lead to early breakage. Damage of the thread will reduce the stability of the instrumentation. Any retrieved devices should be treated in such a manner that reuse in another surgical procedure is not possible.
A device that has been implanted should never be reprocessed or reused under any circumstances. Sterile packaged devices should also never be resterilized. Reprocessing or reuse may compromise the structural integrity of these implants and create a risk of contamination of the implants which could result in patient injury, illness, or death.
Further, the proper selection and compliance of the patient will greatly affect the results. Patients who smoke have been shown to have an increased incidence of non-unions. These patients should be advised of this fact and warned of this consequence. Obese, malnourished, and/or alcohol abuse patients are also poor candidates for spine fusion.
Physician note: although the physician is the learned intermediary between the company and the patient, the important medical information given in this document should be conveyed to the patient.
For US audiences only
Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.
The selection of the proper size, shape, and design of the implant for each patient is crucial to the success of the procedure. Plastic polymer implants are subject to repeated stresses in use, and their strength is limited by the need to adapt the design to the size and shape of human bones. Unless great care is taken in patient selection, proper placement of the implant, and postoperative management to minimize stresses on the implant, such stresses may cause material fatigue and consequent breakage, bending, or loosening of the device before the healing process is complete, which may result in further injury or the need to remove the device prematurely.
The physician's postoperative directions and warnings to the patient and the corresponding patient compliance are extremely important.
MR Conditional
In non-clinical testing the SOVEREIGN™ Spinal System was determined to be MR Conditional. A patient with this device can be scanned safely, immediately after placement under the following conditions:
In non-clinical testing, the SOVEREIGN™ Spinal System produced the following temperature rise during an MRI (Magnetic Resonance Imaging) performed for 15 minutes of scanning (i.e. per pulse sequence) in 1.5 Tesla/64 MHz MR system (Magnetom, Siemens Medical Solutions, Malvern, PA. Software Numaris/4, Version Syngo MR 2002B DHHS Active –shielded, horizontal field scanner) and 3 Tesla/128 MHz, (Excite, HDx, Software 14X.M5, General Electric Healthcare, Milwaukee, WI) MR system:
1.5 Tesla |
3 Tesla |
|
MR system reported, whole body average SAR |
2.9 W/kg |
2.9 W/kg |
Calorimetry Measured values, whole body averaged SAR |
2.1 W/kg |
2.7 W/kg |
Highest temperature change |
1.8°C |
1.7°C |
MR image quality may be compromised if the area of interest is in the same area or relatively close to the position of the SOVEREIGN™ Spinal System. The artifact size information follows:
Pulse sequence |
T1-SE |
T1-SE |
GRE |
GRE |
Signal Void Size |
1,540mm2 |
1,397mm2 |
3,595mm2 |
3,782mm2 |
Imaging plane |
parallel |
perpendicular |
parallel |
perpendicular |
Therefore, optimization of MR imaging parameters to compensate for the presence of this device may be necessary. The maximum artifact size (i.e. as seen on the gradient echo pulse sequence) extends approximately 20mm relative to the size and shape of the SOVEREIGN™ Spinal System.
Physicians should communicate with the patient the following information about MRI with respect to the SOVEREIGN™ Spinal System:
Physicians should instruct patients to:
If the SOVEREIGN™ Spinal System is used in connection with any device which is not MR Conditional, be advised this combination has not been tested in the MR environment and, therefore, higher heating and possible injury to the patient may occur.
Devices may be supplied in a sterile or non-sterile form. Packages for each of the components should be intact upon receipt. Once the seal on the sterile package has been broken, the product should not be re-sterilized. Damaged packages or products should not be used and should be returned to Medtronic.
Unless marked sterile and clearly labeled as such in an unopened sterile package provided by the company, all implants used in surgery must be sterilized by the hospital prior to use. Remove all packaging materials prior to sterilization. Only sterile products should be placed in the operative field. Unless specified elsewhere, these products are recommended to be steam sterilized by the hospital using one of the sets of process parameters in Table 1.
Method |
Cycle |
Temperature |
Exposure time |
Minimum dry time1 |
Steam |
Dynamic-air-removal |
270°F (132°C) |
4 Minutes |
30 Minutes |
Steam |
Dynamic-air-removal |
275°F (135°C) |
3 Minutes |
16 Minutes |
1The minimum dry times were validated using sterilizers having vacuum drying capabilities. Drying cycles using ambient atmospheric pressure may require longer dry times. Refer to the sterilizer manufacturer’s recommendations.
Note: chamber size and chamber load differences may exist between industrial and health care facility sterilizer models. The sterilization parameters listed in Tables 1 and 2 can be achieved in both health care facility and larger, industrial sterilizer models. Because of the many variables involved in sterilization, each medical facility should calibrate and verify the sterilization process (e.g. temperatures, times) used for their equipment.
To report product problems, contact Medtronic.
Recommended directions for use of this system (surgical operative techniques) are available at no charge upon request. If further information is needed or required, contact Medtronic.
Medtronic Sofamor Danek USA, Inc.
©2018 Medtronic Sofamor Danek USA, Inc. All rights reserved.